Source: Health Products Regulatory Authority (IE) Revision Year: 2022 Publisher: Reckitt Benckiser Ireland Ltd, 7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Nurofen Durance 200 mg medicated plaster.
Pharmaceutical Form |
---|
Medicated plaster. Colourless, self-adhesive formulation layer mounted onto a 10 cm by 14 cm flexible flesh-coloured woven support, with a release liner. |
Each medicated plaster contains 200 mg of ibuprofen.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Ibuprofen |
Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation. |
List of Excipients |
---|
Adhesive layer: Macrogol 20000 Backing layer: Woven Polyethylene terephthalate (PET) Release liner: Silicone coated Polyethylene Terephthalate (PET) |
Each sachet is made of composite PET/LDPE/aluminium/LDPE film.
Each sachet contain 2 or 4 medicated plasters. Packs of 2, 4, 6, 8 or 10 medicated plasters.
Not all pack sizes may be marketed.
Reckitt Benckiser Ireland Ltd, 7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
PA0979/032/018
Date of first authorisation: 30th June 2017
Date of last renewal: 25th May 2021
Drug | Countries | |
---|---|---|
NUROFEN | Austria, Cyprus, Germany, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.